Plus Therapeutics holder reports 4.9% stake
Plus Therapeutics, Inc. reporting persons CVI Investments, Inc. and Heights Capital Management, Inc. disclosed beneficial ownership of 9,009,978 shares, representing 4.9% of the outstanding common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Plus Therapeutics, Inc. reporting persons CVI Investments, Inc. and Heights Capital Management, Inc. disclosed beneficial ownership of 9,009,978 shares, representing 4.9% of the outstanding common stock. The filing states there were 171,550,698 Shares outstanding as of March 18, 2026.
The reported shares consist of shares issuable upon exercise of warrants, and exercise is limited so that beneficial ownership would not exceed 4.99%. Heights Capital Management, Inc. serves as investment manager and may exercise shared voting and dispositive power over the reported shares.
Insights
Large holder reports a sub-5% position via warrants managed by an investment manager.
The filing lists 9,009,978 shares as beneficially owned by CVI Investments, Inc. and Heights Capital Management, Inc., equal to 4.9% of 171,550,698 shares outstanding as of March 18, 2026. The reported holdings "consist of Shares issuable upon the exercise of warrants".
Because the warrants include a 4.99% beneficial ownership cap, actual exercisability depends on other aggregated holdings; subsequent disclosures would show any exercises or transfers.
Filing clarifies voting/dispositive authority and limited beneficial ownership disclosure.
The reporting persons state shared voting and dispositive power of 9,009,978 shares and include a note that Heights Capital Management, Inc. is investment manager to CVI Investments, Inc. Signatures show authorization via a previously filed Limited Power of Attorney.
Disclosure labels and the 4.99% exercisability cap are governance-relevant; further filings will reflect any change in exercised warrants or aggregated holdings.
Key Figures
Key Terms
warrants financial
Schedule 13G/A regulatory
Limited Power of Attorney legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does CVI Investments / Heights Capital hold in PSTV?
Does this filing trigger Schedule 13G/A reporting thresholds for PSTV?
AI-generated analysis. How Rhea-AI works. Not financial advice.